TOBRAMYCIN
OTOTOXICITY
REPEATED
COURSES
OF
HIGH
DOSAGE
TREATMENT
IN
CHILDREN
WITH
CYSTIC
FIBROSIS
FIFTYTHREE
PATIENTS
WITH
CYSTIC
FIBROSIS
WERE
TREATED
WITH
LARGE
DOSES
OF
TOBRAMYCIN
SULPHATE
10
MGKG24
H
PATIENTS
RECEIVED
AN
AVERAGE
OF
32
COURSES
EACH
LASTING
10
TO
14
DAYS
THE
PATIENTS
WERE
EXAMINED
WITH
AUDIOMETRIC
AND
VESTIBULAR
TESTS
AND
IN
ONE
PATIENT
A
10YEAROLD
GIRL
WE
FOUND
A
TRANSIENT
HIGH
TONE
LOSS
AT
8000
HZ
BILATERALLY
THAT
MIGHT
BE
ATTRIBUTED
TO
THE
TOBRAMYCIN
TREATMENT
ALL
PATIENTS
HAD
NORMAL
KIDNEY
FUNCTION
HIGH
DOSE
TOBRAMYCIN
TREATMENT
IN
CHILDREN
WITH
NORMAL
KIDNEY
FUNCTION
GIVES
MINIMAL
CLINICAL
RISKS
OF
ADVERSE
OTOTOXIC
EFFECTS
EVEN
AFTER
REPEATED
COURSES
OF
TREATMENT
